In our studies, we tested the hypothesis that human AAT would provide preventative (prophylactic) protection against acute pneumonia, since AAT clinical use is likely optimal as a preventative treatment. This evidence concerns the gene SERPINA1 and susceptibility to pneumonia measurement.